1-1000 Kilograms
$300.00
≥1001 Kilograms
$250.00
Product Description
S-Adenosyl-L-methionine(SAMe) is a common cosubstrate involved in methyl group transfers. SAMe was first discovered in Italy by G. L. Cantoni in 1952, SAMe is a molecule produced constantly by all living cells,can preventing liver cancer, promoting cartilaginous tissue forming and concrescence, may help fight depression, alzheimer's disease, liver disease, and the pain of osteoarthritis,SAMe is now universerally acknowleged as an important pharmaceuticals to treat liver diseases. Nowaday SAMe is commonly used in pharmaceuticals, health care food industry both at domestic and international market.
Certification of Analysis
Appearance | White fine powder |
Odor | Characteristic |
Taste | Characteristic |
Particle Size | 100% pass 80 mesh |
Solubility | Soluble in water |
Loss on Drying | Max 2.0% |
Heavy metals PPM | <10ppm |
Total Plate Count | <1000cfu/g |
Yeast & Mold | <100cfu/g |
E.Coli | Negative |
S. Aureus | Negative |
Salmonella | Negative |
Function&Application
In bacteria, S-Adenosyl-L-methionine is bound by the SAM riboswitch, which regulates genes involved in methionine or cysteine biosynthesis. In eukaryotic cells, S-Adenosyl-L-methionine serves as a regulator of a variety of processes including DNA, tRNA, and rRNA methylation; immune response; amino acid metabolism; transsulfuration; and more. In plants, S-Adenosyl-L-methionine is crucial to the biosynthesis of ethylene, an important plant hormone and signaling molecule.
As of 2012 the evidence was inconclusive as to whether SAM can mitigate the pain of osteoarthritis; clinical trials that had been conducted were too small from which to generalize. A 2016 study concluded that for major depressive disorder, "Given the absence of high quality evidence and the inability to draw firm conclusions based on that evidence, the use of S-Adenosyl-L-methionine for the treatment of depression in adults should be investigated further." .
The S-Adenosyl-L-methionine cycle has been closely tied to the liver since 1947 because people with alcoholic Cirrhosis of the liver would accumulate large amounts of methionine in their blood. While multiple lines of evidence from laboratory tests on cells and animal models suggest that SAM might be useful to treat various liver diseases, as of 2012 SAM had not been studied in any large randomized placebo-controlled clinical trials that would allow an assessment of its efficacy and safety.
Qingdao Xigema Chemical Co., Ltd is a global chemical industry manufacturer and a supplier of pharmaceuticals and intermediates, food and feed additives, herbal extracts, agrochemicals and fine chemicals etc.
The aim of Xigema is a quality policy that "Elements in the system all have been satisfied, Personnel has been trained; Every batch of material is checked, Each procedure guarantees the quality; Every bag of our products is top grade, Service is thoughtful all the time, quality and reputation to increase market share and promote enterprise development. The quality, colors and forms of our products have reached a high level in related chemical industry, which relies on characteristic and advanced processing technology and it has gained a high and reliable reputation from customers at both quality and services.
Xigema has become the "Top 500 Chinese manufacturing companies","Top 20 of global agrochemical sales".Xigema has 21 subsidiaries and holding companies.
Scan the QR code with your phone, or visit the URL